2,003
Views
7
CrossRef citations to date
0
Altmetric
Articles

Induction of telomere shortening and cellular apoptosis by sodium meta-arsenite in human cancer cell lines

, , , , , , & show all
Pages 241-254 | Received 22 May 2017, Accepted 10 Jun 2017, Published online: 01 Jul 2017

References

  • Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89:10114–10118. doi: 10.1073/pnas.89.21.10114
  • Arnoult N, Karlseder J. 2015. Complex interactions between the DNA-damage response and mammalian telomeres. Nat Struct Mol Biol. 22:859–866. doi: 10.1038/nsmb.3092
  • Arshad MN, Nisar MA, Khurshid M, Hussain SZ, Maqsood U, Asghar MT, Nazir J. 2015. Molecular basis of arsenite (As+3)-induced acute cytotoxicity in human cervical epithelial carcinoma cells. Libyan J Med. 10:26875. doi: 10.3402/ljm.v10.26875
  • Artandi SE, DePinho RA. 2010. Telomeres and telomerase in cancer. Carcinogenesis. 31:9–18. doi: 10.1093/carcin/bgp268
  • Aubert G, Lansdorp PM. 2008. Telomeres and aging. Physiol Rev. 88:557–579. doi: 10.1152/physrev.00026.2007
  • Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, Crary SM, Choi J, Sebastiano V, Cherry A, et al. 2011. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature. 474:399–402. doi: 10.1038/nature10084
  • Blasco MA. 2005. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 6:611–622. doi: 10.1038/nrg1656
  • Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:25–34. doi: 10.1016/S0092-8674(01)80006-4
  • Bode A, Dong Z. 2000. Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers. Drug Resist Updat. 3:21–29. doi: 10.1054/drup.2000.0114
  • Burger AM, Dai F, Schultes CM, Reszka AP, Moore MJ, Double JA, Neidle S. 2005. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res. 65:1489–1496. doi: 10.1158/0008-5472.CAN-04-2910
  • Cao X, Deng X, May WS. 2003. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood. 102:2605–2614. doi: 10.1182/blood-2003-01-0211
  • Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S, Haughton M, Baird DM. 2007. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 21:2495–2508. doi: 10.1101/gad.439107
  • Cong YS, Wright WE, Shay JW. 2002. Human telomerase and its regulation. Microbiol Mol Biol Rev. 66:407–425. doi: 10.1128/MMBR.66.3.407-425.2002
  • Dewson G, Kluck RM. 2009. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J Cell Sci. 122:2801–2808. doi: 10.1242/jcs.038166
  • Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol. 35:495–516. doi: 10.1080/01926230701320337
  • Fernald K, Kurokawa M. 2013. Evading apoptosis in cancer. Trends Cell Biol. 23:620–633. doi: 10.1016/j.tcb.2013.07.006
  • Ferrario D, Collotta A, Carfi M, Bowe G, Vahter M, Hartung T, Gribaldo L. 2009. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells. Toxicology. 260:132–141. doi: 10.1016/j.tox.2009.03.019
  • Fujimori J, Matsuo T, Shimose S, Kubo T, Ishikawa M, Yasunaga Y, Ochi M. 2011. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res. 29:1707–1711. doi: 10.1002/jor.21451
  • Funayama R, Ishikawa F. 2007. Cellular senescence and chromatin structure. Chromosoma. 116:431–440. doi: 10.1007/s00412-007-0115-7
  • Glienke W, Chow KU, Bauer N, Bergmann L. 2006. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Leuk Lymphoma. 47:1629–1638. doi: 10.1080/10428190600625398
  • Hamadeh HK, Trouba KJ, Amin RP, Afshari CA, Germolec D. 2002. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol Sci. 69:306–316. doi: 10.1093/toxsci/69.2.306
  • Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. 2000. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 165:4290–4297. doi: 10.4049/jimmunol.165.8.4290
  • Huang TS, Shu CH, Chao Y, Chen SN, Chen LL. 2000. Activation of MAD 2 check protein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis. 5:235–241. doi: 10.1023/A:1009652412399
  • Jeon BG, Kumar BM, Kang EJ, Maeng GH, Lee YM, Hah YS, Ock SA, Kwack DO, Park BW, Rho GJ. 2011a. Differential cytotoxic effects of sodium metaarsenite on human cancer cells, dental papilla stem cells and somatic cells correlate with telomeric properties and gene expression. Anticancer Res. 31:4315–4328.
  • Jeon BG, Kumar BM, Kang EJ, Ock SA, Lee SL, Kwack DO, Byun JH, Park BW, Rho GJ. 2011b. Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins. Cell Tissue Res. 345:149–161. doi: 10.1007/s00441-011-1191-9
  • Jeon BG, Kwack DO, Rho GJ. 2011c. Variation of telomerase activity and morphology in porcine mesenchymal stem cells and fibroblasts during prolonged in vitro culture. Anim Biotechnol. 22:197–210. doi: 10.1080/10495398.2011.624651
  • Karlseder J, Smogorzewska A, de Lange T. 2002. Senescence induced by altered telomere state, not telomere loss. Science. 295:2446–2449. doi: 10.1126/science.1069523
  • Kurokawa K, Akaike Y, Masuda K, Kuwano Y, Nishida K, Yamagishi N, Kajita K, Tanahashi T, Rokutan K. 2014. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells. Oncogene. 33:1407–1417. doi: 10.1038/onc.2013.86
  • Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES. 2006. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 5:187–195. doi: 10.1111/j.1474-9726.2006.00199.x
  • Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. 1992. Telomere end-replication problem and cell aging. J Mol Biol. 225:951–960. doi: 10.1016/0022-2836(92)90096-3
  • Lynn S, Gurr JR, Lai HT, Jan KY. 2000. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 86:514–519. doi: 10.1161/01.RES.86.5.514
  • Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A. 2001. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61:5432–5440.
  • Maida Y, Masutomi K. 2015. Telomerase reverse transcriptase moonlights: therapeutic targets beyond telomerase. Cancer Sci. 106:1486–1492. doi: 10.1111/cas.12806
  • Mender I, Gryaznov S, Shay JW. 2015. A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells. Oncoscience. 2:693–695. doi: 10.18632/oncoscience.213
  • Moon JY, Kim SW, Yun GM, Lee HS, Kim YD, Jeong GJ, Ullah I, Rho GJ, Jeon BG. 2015. Inhibition of cell growth and down-regulation of telomerase activity by amygdalin in human cancer cell lines. Anim Cells Syst. 19:295–304. doi: 10.1080/19768354.2015.1060261
  • Moore MM, Harrington-Brock K, Doerr CL. 1997. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat Res. 386:279–290. doi: 10.1016/S1383-5742(97)00003-3
  • Namgung U, Xia Z. 2000. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J Neurosci. 20:6442–6451.
  • O’Sullivan RJ, Karlseder J. 2010. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol. 11:171–181.
  • Ouyang W, Ma Q, Li J, Zhang D, Liu ZG, Rustgi AK, Huang C. 2005. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 65:9287–9293. doi: 10.1158/0008-5472.CAN-05-0469
  • Pawlak G, Helfman DM. 2001. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev. 11:41–47. doi: 10.1016/S0959-437X(00)00154-4
  • Phatak P, Dai F, Butler M, Nandakumar MP, Gutierrez PL, Edelman MJ, Hendriks H, Burger AM. 2008. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells. Clin Cancer Res. 14:4593–4602. doi: 10.1158/1078-0432.CCR-07-4572
  • Ramírez P, Eastmond DA, Laclette JP, Ostrosky-Wegman P. 1997. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res. 386:291–298. doi: 10.1016/S1383-5742(97)00018-5
  • Ramírez R, Carracedo J, Jiménez R, Canela A, Herrera E, Aljama P, Blasco MA. 2003. Massive telomere loss is an early event of DNA damage-induced apoptosis. J Biol Chem. 278:836–842. doi: 10.1074/jbc.M206818200
  • Reya T, Morrison SJ, Clarke MF, Weissman IL. 2016. Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells. Genom Data. 7:293–296. doi: 10.1016/j.gdata.2016.02.001
  • Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP Jr, Rafii S. 2000. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood. 96:1525–1530.
  • Röth A, Harley CB, Baerlocher GM. 2010. Imetelstat (GRN163L)--telomerase-based cancer therapy. Recent Results Cancer Res. 184:221–234. doi: 10.1007/978-3-642-01222-8_16
  • Rozengurt E. 1983. Growth factors, cell proliferation and cancer: an overview. Mol Biol Med. 1:169–181.
  • Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez AD, De Vizcaya-Ruíz A, Cebrian ME. 2009. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res Genet Toxicol Environ Mutagen. 674:109–115. doi: 10.1016/j.mrgentox.2008.09.021
  • Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, Sperduti I, Stevens MF, D'Incalci M, Blasco M, et al. 2007. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest. 117:3236–3247. doi: 10.1172/JCI32461
  • Schwerdtle T, Walter I, Mackiw I, Hartwig A. 2003. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis. 24:967–974. doi: 10.1093/carcin/bgg018
  • Shay JW, Zou Y, Hiyama E, Wright WE. 2001. Telomerase and cancer. Hum Mol Genet. 10:677–685. doi: 10.1093/hmg/10.7.677
  • Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al. 1997. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:3354–3360.
  • Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, et al. 1998. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 339:1341–1348. doi: 10.1056/NEJM199811053391901
  • Woo SR, Ham Y, Kang W, Yang H, Kim S, Jin J, Joo KM, Nam DH. 2014. KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis. Biomed Res Int. 2014:747415.
  • Xu Y, Goldkorn A. 2016. Telomere and telomerase therapeutics in cancer. Genes (Basel). 7(6):E22. doi: 10.3390/genes7060022
  • Yadav S, Shi Y, Wang F, Wang H. 2010. Arsenite induces apoptosis in human mesenchymal stem cells by altering Bcl-2 family proteins and by activating intrinsic pathway. Toxicol Appl Pharmacol. 244:263–272. doi: 10.1016/j.taap.2010.01.001